Researchers are reporting promising results from early trials of a cancer treatment involving CAR T cells, which may offer hope for patients with hard-to-treat tumors. The treatment has shown potential in fighting various types of cancer, including pancreatic and blood cancer. The outcomes of these trials are being viewed as a positive development, with some institutions highlighting the treatment as one of several recent breakthroughs in cancer research.